A key niche factor for inducing and maintaining ER+ BC dormancy is FGF-2, which is synthesized and exported by stromal fibroblasts and subsequently deposited on HSPGs overlying the stroma [98,99]. The gene discussed is FGF2; the disease is breast cancer.